![Quiver Logo](/static/img/logo-icon.png)
![CALC logo](https://quiver-logos.s3.us-east-2.amazonaws.com/calc.png)
CalciMedica, Inc. Common Stock
CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapies for life-threatening inflammatory diseases with high unmet need. Its proprietary technology targets the inhibition of calcium release-activated calcium channels designed to modulate the immune response and protect against tissue cell injury, with the potential to provide therapeutic benefits in life-threatening inflammatory diseases for which there are no approved therapies.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view CALC Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.
Recent trades of CALC by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by CALC's directors and management
Government lobbying spending instances
New patents grants
Federal grants, loans, and purchases
Recent insights relating to CALC
Recent picks made for CALC stock on CNBC
ETFs with the largest estimated holdings in CALC
Flights by private jets registered to CALC
![Quiver Logo](/static/img/logo-icon.png)